These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Reperfusion synergism: will it be both sustained and safe? Armstrong PW Eur Heart J; 2000 Dec; 21(23):1913-6. PubMed ID: 11071795 [No Abstract] [Full Text] [Related]
7. Glycoprotein IIb/IIIa inhibitors in patients with unstable angina/non-ST-segment elevation myocardial infarction: appropriate interpretation of the guidelines. Antman EM Am Heart J; 2003 Oct; 146(4 Suppl):S18-22. PubMed ID: 14564302 [TBL] [Abstract][Full Text] [Related]
8. The year in non-ST-segment elevation acute coronary syndromes. Giugliano RP; Braunwald E J Am Coll Cardiol; 2005 Sep; 46(5):906-19. PubMed ID: 16139143 [No Abstract] [Full Text] [Related]
9. [Differentiated treatment of diabetics with an acute coronary syndrome]. Hamm CW; Hamann A Dtsch Med Wochenschr; 2006 Nov; 131(47 Suppl 7):S208-10. PubMed ID: 17109250 [No Abstract] [Full Text] [Related]
10. Platelet GP IIb/IIIa inhibition in unstable angina and non-ST segment elevation MI: application of the ACC/AHA guidelines. Young JJ; Choo JK; Kereiakes DJ; ; J Invasive Cardiol; 2003 Feb; 15(2):102-7; quiz 108. PubMed ID: 12556626 [No Abstract] [Full Text] [Related]
11. [Therapeutic strategies to improve the outcome of patients with diabetes mellitus and acute coronary syndrome]. Cavallini C G Ital Cardiol (Rome); 2006 Apr; 7(4 Suppl 1):13S-20S. PubMed ID: 16749287 [TBL] [Abstract][Full Text] [Related]
12. Promise of combined low-molecular-weight heparin and platelet glycoprotein IIb/IIIa inhibition: results from Platelet IIb/IIIa Antagonist for the Reduction of Acute coronary syndrome events in a Global Organization Network B (PARAGON B). Mukherjee D; Mahaffey KW; Moliterno DJ; Harrington RA; Yadav JS; Pieper KS; Gallup D; Dyke C; Roe MT; Berdan L; Lauer MS; Mänttäri M; White HD; Califf RM; Topol EJ Am Heart J; 2002 Dec; 144(6):995-1002. PubMed ID: 12486423 [TBL] [Abstract][Full Text] [Related]
13. Effect of platelet glycoprotein IIb/IIIa receptor blockade with tirofiban on adverse cardiac events in women with unstable angina/non-ST-elevation myocardial infarction (PRISM-PLUS Study). Huynh T; Theroux P; Snapinn S; Wan Y; Am Heart J; 2003 Oct; 146(4):668-73. PubMed ID: 14564321 [TBL] [Abstract][Full Text] [Related]
15. Controversies surrounding platelet glycoprotein IIb/IIIa inhibitors in percutaneous coronary intervention and acute coronary syndromes. Harrington RA Semin Thromb Hemost; 2004 Dec; 30(6):639-47. PubMed ID: 15630670 [TBL] [Abstract][Full Text] [Related]
16. Platelet disaggregation: putting time on your side in acute myocardial infarction. Simon DI; Sakuma M J Am Coll Cardiol; 2004 Jul; 44(2):324-6. PubMed ID: 15261926 [No Abstract] [Full Text] [Related]
18. [Blockers of platelet glycoprotein IIb/IIIa-receptors in the treatment of patients with acute coronary syndrome and during transcutaneous coronary interventions]. Fettser DV; Preobrazhenskiĭ DV; Batyraliev TA; Sidorenko BA; Aĭtach V Ter Arkh; 2009; 81(1):84-7. PubMed ID: 19253720 [No Abstract] [Full Text] [Related]
19. Contemporary view of the acute coronary syndromes. Moustapha A; Anderson HV J Invasive Cardiol; 2003 Feb; 15(2):71-9. PubMed ID: 12556619 [No Abstract] [Full Text] [Related]
20. Acute coronary syndrome: new advances and nursing strategies. Palatnik AM Dimens Crit Care Nurs; 2000; 19(5):22-6. PubMed ID: 11998062 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]